TFX Stock Analysis: Buy, Sell, or Hold?
TFX - Teleflex Incorporated
$115.19
-1.03 (-0.89%)
▼
5d:
+8.82%
30d:
-5.63%
90d:
-6.17%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
TFX is down 3.7% this week, but smart money is accumulating calls. Top strike: $115 2026-04-17 with 3 OI. Call ratio: 100% View Scanner →
Strength: 6.9/10
Get Alerted When TFX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TFX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: TFX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$160.94
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$99.93
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TFX is currently trading at $115.19, which is considered slightly high relative to its 30-day fair value range of $107.61 to $117.70. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.5) compared to its historical average (8.2). At these levels, the market is pricing in 11.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TFX is in a downtrend. The price is approaching resistance at $117.12. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TFX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $130.50 (+12.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TFX is in a downtrend. The price is approaching resistance at $117.12. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TFX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $130.50 (+12.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$107.61 -
$117.70
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
78.1%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($130.50)
- NEUTRAL: Trading at premium valuation - market expects 11.9% growth which is achievable
Fair Price Analysis
30-Day Fair Range
$107.61 -
$117.70
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$6.52
(5.7%)
Support & Resistance Levels
Support Level
$103.08
Resistance Level
$117.12
Current Trend
Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.53
Wall Street Target
$130.50
(+12.3%)
Revenue Growth (YoY)
19.4%
Earnings Growth (YoY)
64.1%
Profit Margin
-45.5%
Valuation Premium vs History
+11.9% premium
PE vs Historical
11.5 vs 8.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.9%
(market-implied from PE analysis)
1-Year Target
$130.05
(+12%)
2-Year Target
$145.53
(+25%)
3-Year Target
$162.84
(+40%)
3-Yr Target (if PE normalizes)
(PE: 12→8)
PE COMPRESSION
$115.80
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 50.4%)
$761.96
(+556%)
Base:
(SPY PE: 11.5, Growth: 50.4%)
$392.24
(+238%)
Bear:
(PE: 8.2, Growth: 50.4%)
$278.93
(+140%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Forward PE: 16.47 | Forward EPS (Implied): $6.43
Bull Case
$127.81
(+21%)
Analyst growth 15.0%, PE expands to 17.3
Base Case
$105.85
(0%)
Market implied 0.0%, PE stable at 16.5
Bear Case
$80.98
(-24%)
Severe decline -15.0%, PE contracts to 14.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: March 30, 2026 10:26 AM ET
Data refreshes hourly during market hours. Next update: 11:26 AM
Data refreshes hourly during market hours. Next update: 11:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TFX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 51 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 54 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 63 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$297 | 61 BUY |
Advanced TFX Option Strategies
Professional options setups generated by AI based on today's TFX price and gamma walls.
